Dr. Marjorie Zauderer got her medical degree from Columbia University College of Physicians & Surgeons and residency from New York Presbyterian Hospital - Columbia Campus. From Memorial Sloan-Kettering Cancer Center, she earned her fellowship. Dr. Zauderer is certified in medical oncology and internal medicine. She has between 6 and 10 years of practice and is currently affiliated with Memorial Sloan Kettering Cancer Center.
Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors.
Dolly S, Wagner AJ, Bendell JC, Kindler HL, Krug LM, Seiwert TY, Zauderer MG, Lolkema M, Apt D, Yeh RF, Fredrickson J, Spoerke JM, Koeppen H, Ware JA, Lauchle JO, Burr...; Clin Cancer Res. 2016 Jan 19.
Dr. Marjorie Zauderer got her medical degree from Columbia University College of Physicians & Surgeons and residency from New York Presbyterian Hospital - Columbia Campus. From Memorial Sloan-Kettering Cancer Center, she earned her fellowship. Dr. Zauderer is certified in medical oncology and internal medicine. She has between 6 and 10 years of practice and is currently affiliated with Memorial Sloan Kettering Cancer Center.
Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors.
Dolly S, Wagner AJ, Bendell JC, Kindler HL, Krug LM, Seiwert TY, Zauderer MG, Lolkema M, Apt D, Yeh RF, Fredrickson J, Spoerke JM, Koeppen H, Ware JA, Lauchle JO, Burr...; Clin Cancer Res. 2016 Jan 19.